Navigation Links
CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients
Date:11/21/2008

ave psoriasis(2), a distressing chronic inflammatory disease. Approximately 80 per cent of these patients have plaque psoriasis, which is characterised by red, scaly patches.(3) Psoriasis can be extremely distressing, and may have a significant impact on patients' quality of life. It is a condition which is frequently physically and psychologically disabling.(4)

Currently, treatments for children and adolescents with psoriasis are mainly limited to topical medications that are applied directly to the skin. Whilst these treatments may be effective at reducing the visible skin lesions and associated symptoms, they are generally used for mild and moderate forms of paediatric psoriasis.

Enbrel is an innovative drug that works by reducing the chronic inflammation that leads to plaque psoriasis.

To access further media information relating to this press release, additional information on Enbrel and future media announcements, please register on the media centre athttp://www.wyeth.eu. If you subscribe to receive our emails you will get updates as soon as new content added to the site. Please note you will be able to unsubscribe at any time and we will not pass your details to any third party.

Notes To Editors

"The 211 study: Enbrel(R) in children and adolescents(5)

The 48 week study involved 211 patients with moderate-to-severe psoriasis aged four to 17 years. During the first 12 weeks of the trial, patients received once weekly injections of either placebo or 0.8 mg of Enbrel per kilogram of body weight up to a maximum of 50 mg. For the next 24 consecutive weeks, all patients went on to receive Enbrel. The 138 patients still participating at week 36 were then re-randomised to receive either placebo or Enbrel in order to investigate whether stopping treatment would lead to any rebound.

At week 12, almost tw
'/>"/>

SOURCE Wyeth Pharmaceuticals Limited
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Task Force Recommends Screening for Hearing Loss in All Newborns
2. FDA Advisory Committee Unanimously Recommends Approval of Ustekinumab for Treatment of Moderate to Severe Plaque Psoriasis
3. FDA Advisory Committee Unanimously Recommends U.S. Approval of Sugammadex, the First and Only Selective Relaxant Binding Agent
4. Independent Data Safety Monitoring Board Recommends Continuation of Sangarts Pivotal Phase III Trials of Hemospan(R) Following Second Interim Review
5. CHMP Recommends Expanded Use of Angiox(R) (Bivalirudin) in Europe for Patients With Acute Coronary Syndromes
6. Tibotec Data Presented at ICAAC and HIV9 Follow Key Regulatory Approvals for Anti-HIV Compounds
7. Berlin Hearts EXCOR(R) Pediatric Receives Unconditional Investigational Device Exemption (IDE) Approval
8. Anthera Completes Special Protocol Assessment With FDA and Receives EMEA Scientific Advice on Development Path Toward Varespladib Approval
9. Helix Receives Approval to Open Sites in Germany for its Ongoing Clinical Trial With Topical Interferon Alpha-2b in Patients With Ano-Genital Warts
10. Sunshine Heart Announces IDE Approval To Begin C-Pulse U.S. Clinical Feasibility Trial
11. Nexgen Spine Receives CE Mark Approval for the Physio-L(R) Artificial Disc
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... 2015  Lors du salon Control 2015 de ... 5510), North Star Imaging Europe (NSI, www.4nsi.eu ... spécialement conçu pour la métrologie. Cette nouvelle machine ... la CXMM 50, a été développée dès le ... à offrir à l,utilisateur un outil de développement ...
(Date:5/4/2015)... HAVEN, Conn. , May 4, 2015 /PRNewswire/ ... chosen by the American Optometric Association (AOA) to ... delivery and outcomes for the millions of patients ... Measures and Outcomes Registry for Eyecare (MORE) ... will securely facilitate efficient secondary uses of essential ...
(Date:5/4/2015)... EspeRare today announced that the ... Designation (ODD) for rimeporide, its lead compound for the ... rare, life-threatening disease affecting boys early in childhood that ... most common and serious form of paediatric muscular dystrophies. ... inhibitor, originally developed by Merck Serono in the intended ...
Breaking Medicine Technology:NSI sera présente lors du salon Control 2015, du 5 au 8 mai à Stuttgart, en Allemagne : axer la GMAO vers une nouvelle dimension 2American Optometric Association, Prometheus Research to Create Transformative Health Outcomes Registry 2EspeRare's Investigational Compound Rimeporide Receives European Orphan Drug Designation in Duchenne Muscular Dystrophy 2
... BOSTON, Aug. 23 Do people cringe when you,sing? ... 1 in 20,people truly has amusia, the technical term ... bad singing voices hear music just fine.,Amusics are a ... out,differences in pitch or follow the simplest tunes, reports ...
... Iomai Corporation,(Nasdaq: IOMI ) today announced that ... double-blind Phase 2 field study of a patch-based,vaccine ... "late breaker",presentation at Interscience Conference on Antimicrobials and ... to 20. The abstract, "Transcutaneous Immunization with ...
Cached Medicine Technology:Tone Deafness Explained, from the Harvard Health Letter 2Iomai Announces Data from Phase 2 Field Study of Travelers' Diarrhea Vaccine Accepted for Presentation at ICAAC 2
(Date:5/4/2015)... 2015 “ Food Cost Calculator ” was ... takes a look at the latest and coolest applications on ... host of AppWatch and technology expert, conducted the app review ... to manage and efficiently calculate food costs. , The restaurant ... fact, the industry has an estimated 1.8 trillion dollar impact ...
(Date:5/4/2015)... (PRWEB) May 04, 2015 Fast on ... Gladen’s documentary Trace Amounts, and Allison Folmar, JD, join ... conference held internationally. , On Sunday, May 24, the ... from autism possible?" Are you interested in Ryan Hinds' ... There: winning our war against autism was written ...
(Date:5/4/2015)... May 04, 2015 The ... released the first-ever congenital heart disease (CHD) ... Laboratory (PCCL) accreditation. Driven by the latest ... a comprehensive review of interventional procedures in ... disease. , “The ACE CHD Standards for ...
(Date:5/4/2015)... 04, 2015 Peacock Alley knows ... He said, “My mother was the most beautiful woman I ... in lovely, feminine prints and textures to remind ... further than the Eloise Robe to get you there. The ... cap sleeve and tapered waist. It is available in small/medium ...
(Date:5/4/2015)... “St. Louis has long represented opportunity and ... so it is the perfect place for Zerorez to ... Litalien, Chief Development Officer for Zerorez. “We have ... provide veterans with a $10,000 discount on our franchise ... a number of Military Veterans in its ranks including ...
Breaking Medicine News(10 mins):Health News:An Application to Manage a Successful Restaurant Was Featured on NewsWatch Television 2Health News:Perhaps the most important information families touched by autism will ever hear is available this month at international conference in Chicago 2Health News:Perhaps the most important information families touched by autism will ever hear is available this month at international conference in Chicago 3Health News:Perhaps the most important information families touched by autism will ever hear is available this month at international conference in Chicago 4Health News:Accreditation for Cardiovascular Excellence (ACE) Publishes New Standards for Pediatric and Adult Congenital Cardiac Catheterization Laboratories 2Health News:Feminine Classics for Mother's Day Gifts from Peacock Alley 2Health News:Zerorez® Creates “Gateway” for Veterans--Announces VetFran Participation. Plans Expansion into the St. Louis Region. 2Health News:Zerorez® Creates “Gateway” for Veterans--Announces VetFran Participation. Plans Expansion into the St. Louis Region. 3
... March 14 The American public,believes doctors and physicians ... and they want doctors to make decisions about patient ... be allowed to own,hospitals where they work and that ... A recent Lake Research Partners, national survey(1) shows ...
... were African-American were much more likely to suffer ... Surgery may provide only short-term relief for some ... Children,s Hospital Medical Center. , Adenotonsillectomy surgery is ... (SDB) in children. It is the most common ...
... 14 Sergeant,s Pet Care Products,today announces ... of Virbac,Corporation. The brands and technology acquired ... include internal and external health care,products, dental ... recognized,brands include WormXPlus(TM), WormX(R), Petrodex(R), Zema(R), Mardel(R),and ...
... report, COLORADO SPRINGS, Colo., March 14 ... for heart disease as early as,the toddler years, ... Conference on Cardiovascular Disease Epidemiology and,Prevention., It ... cardiovascular disease in,adults are initiated and progress silently ...
... is available in French and German . ... basic biological questions ranging from the role of lipids in ... 79 research groups include 39 from the two federal polytechnic ... Swiss universities, one group is part of the Swiss Institute ...
... not always manifested in children as dejection and anhedonia. ... features may be weeping, irritability or defiance, as explained ... Ulm University in the new edition of Deutsches rzteblatt ... signs of depression in infants are often screaming, restlessness, ...
Cached Medicine News:Health News:New Poll From Lake Research Shows Americans Support Allowing Physicians to Own and Operate Hospitals 2Health News:New Poll From Lake Research Shows Americans Support Allowing Physicians to Own and Operate Hospitals 3Health News:Surgery Only Works for Some Kids with Sleep Apnea 2Health News:Sergeant's(R) Pet Care Products Acquires the Consumer Brand Division of Virbac Corporation 2Health News:Toddlers Affected Most by Secondhand Smoke Exposure at Home 2Health News:Toddlers Affected Most by Secondhand Smoke Exposure at Home 3Health News:Toddlers Affected Most by Secondhand Smoke Exposure at Home 4Health News:Swiss Systems Biology Initiative announces Flagship Projects 2
The unique MR-frame and its indicators are made of a highly tensile and fibre reenforced Epoxyd material....
VG2 PLIF (Trapezoid) Posterior lumbar interbody fusion. Frozen preservation. Consists of two outer cortical planks, center cancellous plank, all from the same donor, held together by two press-fit co...
VG1 ALIF (Anterior) Anterior lumbar interbody fusion. Frozen freeze-dried preservation....
Allograft implants can be easily used to repair and promote the healing of a wide variety of bone and other tissue defects....
Medicine Products: